| Announce Date | 08/06/2025 |
| EPS Normalized Actual | $0.13 (Beat by $0.14) |
| EPS GAAP Actual | $0.13 (Beat by $0.14) |
| Revenue Actual | $0.103138B |
| Revenue Surprise | Beat by $103.138M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $-0.0289016 |
| EPS GAAP Estimate | $-0.0289016 |
| Revenue Estimate | $0.020418795B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 2.31313 | 46.22 | 1.61469 | 3.16995 | 1 |
| Dec 2028 | 2.88488 | 37.06 | 1.49118 | 4.24421 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.16 | 0.16788218 | 0.103138B | 100% | 68M |
| FQ1 2025 (Mar 2025) | -0.16 | -0.14949068 | 0.076256B | 100% | 47.29M |
| FQ4 2024 (Dec 2024) | -0.0519 | -0.01564196 | 0.036655B | 100% | 32.42M |
| FQ3 2024 (Sep 2024) | -0.88 | -0.8449474 | 0.005624B | 100% | 5.36M |
| FQ2 2024 (Jun 2024) | -0.88 | -2.22259 | 0B | NAN% | 0M |
| FQ4 2007 (Dec 2007) | 0 | 0 | 0B | NAN% | 0M |
| FQ4 2012 (Dec 2012) | 0 | 0 | 0B | NAN% | 0M |
| FQ4 2013 (Dec 2013) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.0289016
Consensus Revenue Estimates
0.020418795B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.03152873 | -- | 0.000796155382 | 0.07150013 | 1 |
| FQ3 2026 (Sep 2026) | 0 | -- | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | -0.00788218 | 2129.9 | -0.01787503 | -0.000199038782 | 1 |
| FQ1 2026 (Mar 2026) | -0.01576437 | -914.95 | -0.03575007 | -0.000398077817 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.08B | -- | 0.02B | 0.16B | 4 |
| FQ3 2026 (Sep 2026) | 0.05B | -- | 0.01B | 0.1B | 4 |
| FQ2 2026 (Jun 2026) | 0.04B | -137.27 | 0.01B | 0.09B | 4 |
| FQ1 2026 (Mar 2026) | 0.04B | -110.52 | 0.01B | 0.07B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
4
EPS # of in-lines
3
Revenue # of Beats
4
Revenue # of Misses
0
Revenue # of in-lines
4
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.00788218 | 0.16 | 0.16788218 | 104.93% |
| FQ1 2025 (Mar 2025) | -0.01050932 | -0.16 | -0.14949068 | 93.43% |
| FQ4 2024 (Dec 2024) | -0.03625804 | -0.0519 | -0.01564196 | 30.14% |
| FQ3 2024 (Sep 2024) | -0.0350526 | -0.88 | -0.8449474 | 96.02% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.88 | -2.22259 | 252.57% |
| FQ4 2007 (Dec 2007) | 0 | 0 | NAN% | |
| FQ4 2012 (Dec 2012) | 0 | 0 | NAN% | |
| FQ4 2013 (Dec 2013) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.04B | $0.1B | $68M | 65.94% |
| FQ1 2025 (Mar 2025) | $0.03B | $0.08B | $47.29M | 62.01% |
| FQ4 2024 (Dec 2024) | $0B | $0.04B | $32.42M | 88.43% |
| FQ3 2024 (Sep 2024) | $0B | $0.01B | $5.36M | 95.33% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2007 (Dec 2007) | $0B | $0B | $0M | NAN% |
| FQ4 2012 (Dec 2012) | $0B | $0B | $0M | NAN% |
| FQ4 2013 (Dec 2013) | $0B | $0B | $0M | NAN% |